Gain access to actionable insights from our expert analysts
Our teams of experienced healthcare analysts produce regular whitepapers on the issues and trends affecting the pharmaceutical and medical device markets, and offer complimentary trend reports, factsheets and sample reports from across our wide portfolio. Request your free copy of any of the content below to gain access to valuable data, analysis and expert opinion.
Published: 16 Jan 2017
In this whitepaper, GlobalData discusses the recent pledge by the Australian government to invest in healthcare to improve access to life-saving medicines for the Australian people and provides independent insight into the merits and faults of Medicare and the Pharmaceuticals Benefits Scheme (PBS).
Published: 16 Dec 2016
In this whitepaper, GlobalData's healthcare research features prominently in Arena International's Clinical Trials Yearbook 2017, providing robust insight into current and anticipated trends in the drug development space. It includes GlobalData's five-year retrospective analysis of terminated clinical trials.
Published: 07 Dec 2016
In this whitepaper, GlobalData discusses the ten major trends it believes will greatly influence the direction of the global medical technology markets in 2017, including the rise of bolt-on acquisitions, the decline of venture capital, and the boom in robo-assisted procedures.
Published: 21 Nov 2016
In this whitepaper, GlobalData discusses presentations from this year's annual meeting of the American Society for the Study of Liver Disease (AASLD), and what the future treatment landscape might look like for patients suffering from chronic HCV infections.
Published: 24 Jun 2016
In this whitepaper, GlobalData discusses the major challenges faced by the UK pharmaceutical and medical device industries following the UK’s referendum, in which a clear majority of voters indicated their desire for the UK to leave the European Union. It provides analysis of the impact of this outcome on five key areas, including regulatory impacts, research and development, access to talent, intellectual property rights and market access.